tirzepatide syringes Eli Lilly sues companies selling alternative versions of its weight loss drug Lilly releases Zepbound® (tirzepatide) single-dose

Lipohypertrophy presents as larger, persistent lumps with a characteristic rubbery texture

Apitegromab works via a completely different mechanism - it targets myostatin in skeletal muscle and is not intended to drive weight loss directly

Notably, these drugs reduce weight primarily by reducing energy intake, via activation of the GLP-1 receptor on multiple sites of action primarily in the central nervous system, although the most relevant sites of action, and the neural circuits recruited remain contentious

GLP-1 Complete contains only 1.3 grams

The Bottom Line Retatrutide is doing something the obesity field hasnt seen before: it simultaneously outperforms every approved agent on weight loss, normalizes liver fat, improves glycemic control beyond existing diabetes therapies, eases osteoarthritis pain, and meaningfully reduces sleep apnea severity all without plateauing out to two years